Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | KDM4A | O75164 | 2/20 | 0.47 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | CHAT | P28329 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29620207 | 1.00 | RAB9A (0.47) | RAB9AKMT2AMEN1NPC1KDM4A | |
| SCHEMBL1981105 | 1.00 | RAB9A (0.47) | RAB9AKMT2AMEN1NPC1KDM4A | |
| Hydrochloric Acid SCHEMBL11387733 | 0.98 | RAB9A (0.46) | RAB9AKMT2AMEN1NPC1KDM4A | |
| Hydrochloric Acid SCHEMBL11387731 | 0.98 | RAB9A (0.46) | RAB9AKMT2AMEN1NPC1KDM4A | |
| SCHEMBL12657241 | 0.85 | RAB9A (0.47) | RAB9AKMT2AMEN1NPC1KDM4A | |
| SCHEMBL9588524 | 0.81 | RAB9A (0.67) | RAB9AKMT2AMEN1NPC1KDM4A | |
| SCHEMBL29620208 | 0.81 | RAB9A (0.67) | RAB9AKMT2AMEN1NPC1KDM4A | |
| SCHEMBL1898847 | 0.81 | RAB9A (0.67) | RAB9AKMT2AMEN1NPC1KDM4A | |
| SCHEMBL12657236 | 0.81 | MEN1 (0.47) | RAB9AKMT2AMEN1NPC1KDM4A | |
| SCHEMBL19003852 | 0.80 | MEN1 (0.52) | RAB9AKMT2AMEN1NPC1KDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4229482-B1 | POLYVINYL ACETATE BASED PHOTOPOLYMER | SHOWA CHEM (JP) | 2024-09-11 | — | — | EP | disclosed |
| US-11860539-B2 | Polyvinyl acetate based photopolymer | SHOWA KAKO CORPORATION (JP) | 2024-01-02 | — | — | US | disclosed |
| US-20230288803-A1 | POLYVINYL ACETATE BASED PHOTOPOLYMER | SHOWA KAKO CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| EP-4229482-A1 | POLYVINYL ACETATE BASED PHOTOPOLYMER | Showa Kako Corporation (JP) | 2023-08-23 | — | — | EP | disclosed |
| US-11369559-B2 | Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer | L'OREAL (FR) | 2022-06-28 | — | — | US | disclosed |
| WO-2022081652-A1 | POLYVINYL ACETATE BASED PHOTOPOLYMER | SHOWA KAKO CORPORATION (JP) | 2022-04-21 | — | — | WO | disclosed |
| US-20220087920-A1 | COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION | L'OREAL (FR) | 2022-03-24 | — | — | US | disclosed |
| CN-108367167-B | Method for treating keratin materials using a composition comprising a modified photodimerisable polymer | 莱雅公司 | 2021-12-31 | — | — | CN | disclosed |
| EP-3897858-A1 | COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION | L'OREAL (FR) | 2021-10-27 | — | — | EP | disclosed |
| CN-113195058-A | Composition comprising a modified photodimerisable polymer and an alkaline agent and/or an aminoalkoxysilane derivative and treatment process for implementing the composition | 莱雅公司 | 2021-07-30 | — | — | CN | disclosed |
| WO-2010007425-A2 | MEDICAL IMPLANT | AGT SCIENCES LTD (GB) | 2010-01-21 | — | — | WO | disclosed |
| US-5246815-A | Multilayer light sensitive element with polymer films | GEN. DIRECTOR OF THE AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1993-09-21 | — | — | US | disclosed |
| EP-0252151-B1 | PHOTOSENSITIVE MATERIAL FOR SCREEN PROCESS | Japan as represented by Director-General, Agency of Industrial Science and Technology (JP) | 1993-04-14 | — | — | EP | disclosed |
| EP-0252150-B1 | PHOTOSENSITIVE RESIN COMPOSITION FOR SCREEN PROCESS | Japan as represented by Director-General, Agency of Industrial Science and Technology (JP) | 1992-12-30 | — | — | EP | disclosed |
| EP-0252152-B1 | PHOTOSENSITIVE EMULSION FOR COATING PLASTIC FILM | Japan as represented by Director-General, Agency of Industrial Science and Technology (JP) | 1992-05-13 | — | — | EP | disclosed |
| US-4920030-A | Containing photocrosslinkable polyvinyl alcohol | GENERAL DIRECTOR OF THE AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1990-04-24 | — | — | US | disclosed |
| EP-0252151-A1 | PHOTOSENSITIVE MATERIAL FOR SCREEN PROCESS | Japan as represented by Director-General, Agency of Industrial Science and Technology (JP) | 1988-01-13 | — | — | EP | disclosed |
| EP-0252152-A1 | PHOTOSENSITIVE EMULSION FOR COATING PLASTIC FILM | Japan as represented by Director-General, Agency of Industrial Science and Technology (JP) | 1988-01-13 | — | — | EP | disclosed |
| EP-0252150-A1 | PHOTOSENSITIVE RESIN COMPOSITION FOR SCREEN PROCESS | Japan as represented by Director-General, Agency of Industrial Science and Technology (JP) | 1988-01-13 | — | — | EP | disclosed |
| US-4339524-A | VINYL ACETATE, VINYL ALCOHOL ACETAL | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE AND INDUSTRY (JP) | 1982-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220087920-A1 | COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION | ACP1, ALAD, PHOSPHO1 | RAB9A 3342/4885KMT2A 437/4885MEN1 1506/4885 |
| US-11369559-B2 | Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer | KRT18, KRTCAP2, CKAP4 | RAB9A 3564/4885KMT2A 2113/4885MEN1 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.